The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     
 

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Huang, L.-Y.
Right arrow Articles by Golding, B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Huang, L.-Y.
Right arrow Articles by Golding, B.
The Journal of Immunology, 2005, 175: 3964-3970.
Copyright © 2005 by The American Association of Immunologists

Th1-Like Cytokine Induction by Heat-Killed Brucella abortus Is Dependent on Triggering of TLR9

Li-Yun Huang*, Ken J. Ishii{dagger}, Shizuo Akira{dagger}, Julio Aliberti{ddagger} and Basil Golding1,*

* Division of Hematology, Office of Blood Research and Review, Center for Biologics Evaluation and Research, Food and Drug Administration, Bethesda, MD 20892; {dagger} Exploratory Research for Advanced Technology, Japan Science and Technology Agency and Department of Host Defense Research Institute for Microbial Diseases, Osaka University, Osaka, Japan; and {ddagger} Department of Immunology, Duke University Medical Center, Durham, NC 27701


   Abstract
Top
 Abstract
Introduction
 Materials and Methods
 Results
 Discussion
 Disclosures
 References
 
In this report we provide evidence, for the first time, that bacterial DNA in the context of heat-killed Brucella abortus (HKBA) engages TLR9 in dendritic cells (DC), resulting in a Th1-like cytokine response. This is based on the findings that HKBA induction of IL-12p40 is: 1) abolished in DC from TLR9–/– mice; 2) blocked by suppressive oligodeoxynucleotides; 3) simulated by bacterial DNA derived from HKBA; and 4) abrogated by DNase or methylation of the DNA from HKBA. Furthermore, the effect of HKBA can be inhibited by chloroquine, indicating that endosomal acidification is required and supporting the notion that DNA from HKBA is interacting with TLR9 at the level of the endosome, as is the case with CpG oligodeoxynucleotides. In addition to DC, HKBA can elicit IL-12p40 secretion from macrophages, in which case the effect is wholly MyD88 dependent but only partially TLR9 dependent. This probably explains why HKBA effects in vivo are only partially reduced in TLR9–/–, but absent in MyD88–/– mice. Because of their intimate interactions with T cells, the DC response is most likely to be critical for linking innate and adaptive immune responses, whereas the macrophage reaction may play a role in enhancing NK cell and bystander immune responses. In addition to IL-12p40, HKBA induces other Th1-like cytokines, namely, IFN-{alpha} and IFN-{gamma}, in a TLR9-dependent manner. These cytokines are important in protection against viruses and bacteria, and their induction enhances HKBA as a potential carrier for vaccines.


   Introduction
Top
 Abstract
 Introduction
Materials and Methods
 Results
 Discussion
 Disclosures
 References
 
Brucella abortus is an intracellular pathogen that resides mainly in macrophages and causes disease in livestock and in humans (1, 2, 3, 4, 5, 6, 7). Heat-killed B. abortus (HKBA)2 has been shown by us and others to have many effects on the immune system in mice and humans (1, 8). After injection in mice, HKBA is taken up by dendritic cells (DC) and macrophages. The DC migrate to T cell areas in the spleen and secrete IL-12 (9). Neighboring T cells, bearing appropriate TCRs, are activated and release IFN-{gamma}, i.e., a Th1-like response (10, 11). In humans, HKBA induces IFN-{gamma} from T and NK cells (12) and MIP-1{alpha}{beta} chemokines, mainly from macrophages (13).

A unique characteristic of HKBA is its ability to stimulate B cells and CTL even in the absence of T cell help (14, 15). This attribute may be particularly beneficial in HIV-1-infected persons who have impaired and/or reduced T cell helper function (16). We have shown that HIV-1 peptide or proteins chemically conjugated to HKBA are capable of inducing Ab and CTL responses even in CD4 T-cell-depleted animals (15, 17, 18).

Although the effects of HKBA on the immune system have been studied in some detail, the molecular interactions between ligands on HKBA and their respective host receptors have only recently become the subject of experimental investigation. In a previous study, we showed that HKBA can activate the innate immune system by acting on members of the TLR family (19). TLRs, numbered 1–11, have been identified as receptors for microorganisms and their products. Most of the TLRs require the adaptor molecule, MyD88, for signal transduction, exceptions being TLR3 (acts via Toll-IL-1R domain-containing adapter inducing IFN-{beta}) and TLR4 (acts via MyD88 or Toll-IL-1R domain-containing adapter inducing IFN-{beta}) (20, 21, 22, 23). We showed that HKBA activates DC and macrophages to secrete TNF and IL-12p40 by two distinct TLR pathways. TNF secretion was TLR2 dependent, whereas IL-12p40 secretion was TLR2 independent, but MyD88 dependent (19). The TLR involved in IL-12p40 induction remained to be elucidated.

In this report, we studied the role of TLR9 in HKBA-induced IL-12 production. We first focused on the interaction between HKBA and DC, because these are very effective APCs capable of migrating to T cell areas in the spleen after Ag encounter, and they secrete IL-12p40, thus providing the crucial link between the innate and adaptive immune responses. The results in this study show that HKBA stimulates DC via TLR9 to secrete IL-12p40. Furthermore, this effect can be simulated by DNA derived from HKBA and can be blocked by addition of suppressive oligodeoxynucleotides (ODNs). The effect of DNA from HKBA is abrogated by DNase I treatment or methylation. In addition, the effects of HKBA on IL-12p40 induction can be blocked by chloroquine, thereby suggesting that endosomal acidification is required and implying that HKBA is internalized and localizes to the endosome. The consequence of these interactions is that Th1-like responses are initiated as shown by induction of IFN-{gamma} in wild-type (WT) but not TLR9–/– mice.

In addition to IL-12p40, we show, for the first time, that HKBA induces IFN-{alpha} in a TLR9-dependent manner. IFN-{alpha} secretion in mice has been shown to result from stimulation of plasmacytoid DC with D (also known as A)-type CpG ODNs (24, 25, 26). IFN-{alpha} plays an important role in establishing a Th1-like response and has both antiviral and antibacterial properties (27, 28, 29, 30), thus enhancing HKBA as a potential vaccine delivery system.


   Materials and Methods
Top
 Abstract
 Introduction
 Materials and Methods
Results
 Discussion
 Disclosures
 References
 
Mice and in vivo stimulation

Female C57BL/6 mice were obtained from The Jackson Laboratory. MyD88–/– and TLR9–/– were provided by Dr. S. Akira (Osaka University, Osaka, Japan) (31, 32). MyD88–/– and TLR9–/– were backcrossed six times to the C57BL/6 background and bred in a Center for Biologics Evaluation and Research (CBER) animal facility. Mice were used under protocols approved by the CBER Animal Care and Use Committee.

For in vivo stimulations, mice were injected i.p. with HKBA (108 organisms), CpG ODN (100 µg), or PBS. In some experiments, mice received suppressive or control ODN (150 µg) 5–10 min before HKBA injection. At the indicated time points after injection, sera were collected and stored at –20°C until assayed. In each in vivo experiment, at least three mice were used per stimulation and repeated at least twice. The SE bars represent variability between individual mice.

Reagents

HKBA 1119.3 was kindly provided by Dr. B. Martin at the U.S. Department of Agriculture (Ames, IA) and was washed extensively with PBS before use. Soluble Toxoplasma gondii tachyzoite Ag (STAg) was provided by Dr. A. Sher (National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD) and was prepared as previously described (33). LPS derived from Escherichia coli and chloroquine were obtained from Sigma-Aldrich.

Enzyme treatment of DNA

B. abortus DNA (DNA-BA) was extracted from B. abortus using the Qiagen genomic DNA protocol and reagents as previously described (34).

Methylation and DNase I treatment of DNA were performed as previously described (35, 36). In brief, DNA was treated with SssI CpG methylase (3 U/µg of DNA) in NE Buffer 2 supplement with S-adenosylmethionine (SAM; New England Biolabs) at 37°C. Methylation of DNA was confirmed by the loss of HpaII (New England Biolabs) cleavage susceptibility. Complete methylation was achieved after incubation and repeated replenishment of SAM and SssI methylase for 24 h. DNA was then extracted with phenol-chloroform-isoamyl alcohol, precipitated with ethanol, and dissolved in PBS.

For DNase I treatment, DNA was treated with DNase I (6 U/µg of DNA) from Roche Applied Science at 37°C for 2–4 h. Before addition to spleen cells, genomic DNA was boiled for 5 min and quenched on ice for 5 min. Complete digestion of DNA by DNase I and methylation of DNA were confirmed by electrophoresis on 1% agarose gels.

Analysis of CG dinucleotide content in genomic DNA

B. abortus (9-941) was sequenced in its entirety and is available from GenBank. The genome is 3.3 Mb and composed of two circular chromosomes; Chr I (2.12 Mb) and Chr II (1.16 Mb) are AEO17223and AEO17224 respectively (37). The frequency of CpG dinucleotide content in genomic DNA of B. abortus was determined by Gene Runner version 3.05 for Windows (free DNA program, <www.generunner.com>).

ODNs

Phosphorothioate-modified ODNs were synthesized at the CBER core facility (Bethesda, MD). The following ODNs were used: immunostimulatory ODN 1555 (CpG) (GCTAGACGTTAGCGT), suppressive ODN H154 (sODN) (CCTCAAGCTTGAGGGG), and control ODN 1471 (cODN) (TCAAGCTTGA) (38).

Cell isolation and in vitro stimulation

Splenic DC were purified as previously described (19, 39). Briefly, Spleens harvested from mice were digested with Liberase CI (Roche Applied Science). Low-density leukocytes were then obtained after centrifugation in a dense-BSA gradient. Enriched DC were further purified using anti-CD11c MACS beads and passed through a MACS+ selection column (Miltenyi Biotec). The cells purified from the column were routinely 70–85% CD11c+, as determined by flow cytometry.

Murine peritoneal macrophages were elicited by i.p. injection of 2 ml of 3% thioglycolate medium and subsequently were harvested by peritoneal lavage 3–4 days after injection. These cells (106 cells per milliliter in 24-well plates) were incubated for 3 h, and adherent cells were used as peritoneal macrophages.

For in vitro stimulation, low-density cells or enriched DC were cultured in complete RPMI medium (19) at a concentration of 1–5 x 106 cells per milliliter or splenocytes at a concentration of 107 cells per milliliter. These cultures were incubated in the presence or absence of different stimuli in RPMI 1641 supplemented with 10% heat-inactivated FBS, penicillin-streptomycin, HEPES buffer, 2-ME, nonessential amino acids, pyruvate, and glutamine. In some experiments, cells were pretreated with chloroquine or sODN for 1–3 h before the addition of HKBA or CpG. After stimulation, culture supernatants were collected after overnight incubation and stored at –20°C until assayed.

Detection of cytokines

The cytokines IL-12p40 and IFN-{gamma} was measured by using commercial ELISA kits from R&D Systems or Pierce Endogen, whereas IFN-{alpha} was measured by using commercial ELISA kits from PBL Biomedical Laboratory. Values are expressed as the means with the SD for duplicate or triplicate samples.

Statistical analyses

Results were expressed as the mean ± SE (for in vivo experiments) or mean ± SD (for in vitro experiments). Data were analyzed by the unpaired t tests using GraphPad Prism version 3.00 for Windows (GraphPad). Differences were considered statistically significant at p < 0.05.


   Results
Top
 Abstract
 Introduction
 Materials and Methods
 Results
Discussion
 Disclosures
 References
 
Secretion of IL-12p40 after HKBA stimulation of murine splenic DC in vitro is MyD88 and TLR9 dependent

Previously, using WT and TLR-deficient mice, we showed that HKBA-induced IL-12p40 production in murine DC was MyD88 dependent but TLR2/4 independent. To determine whether TLR9 played a role, we added HKBA to DC from TLR9–/– mice and found that IL-12p40 was reduced to background levels, indicating that IL-12p40 induction by HKBA is TLR9 dependent (Fig. 1). In contrast, stimulation of IL-12p40 by STAg, which is CCR5 and MyD88 dependent was unaffected (40).



View larger version (20K):
[in this window]
[in a new window]
  		FIGURE 1. Induction of IL-12p40 by HKBA and DNA from HKBA in DC is TLR9 dependent. HKBA (108 organisms per milliliter), DNA-BA (25 µg/ml), CpG ODN (2 µM), or STAg (1 µg/ml) were added to enriched DC from spleens of WT and TLR9–/– mice. Supernatants were collected after overnight incubation and assayed for IL-12p40 by ELISA. The mean values and SDs are shown. *, Values of p < 0.05. The data shown are representative of three similar experiments.

 
Because HKBA retains the bacterial DNA component, it was of interest to examine the role of this DNA in the induction of IL-12p40 by DC. DNA purified from HKBA and CpG ODN were able to stimulate IL-12p40 from DC from WT mice but the response was abrogated in TLR9–/– mice (Fig. 1).

Methylation and DNase I treatment abrogate the ability of DNA from HKBA to induce IL-12p40

Bacterial DNA, unlike eukaryotic DNA, contains a high frequency of unmethylated CpG motifs (41). Based on analysis of ~10% of the genome (330,000 bp), the frequency of CpG dinucleotide content in B. abortus was determined to be 0.0916 (see Materials and Methods). This is higher than the expected CpG dinucleotide frequency for bacterial DNA, ~1 in 16 bases (0.0625) (41, 42), and higher than that reported for E. coli as 0.0747 (43). Thus based on CpG content, DNA from HKBA should be immunostimulatory to an extent similar to E. coli.

To establish the role of methylation in the ability of Brucella DNA to stimulate IL-12p40, the DNA from HKBA was methylated. Complete methylation was confirmed by resistance to HpaII treatment, and complete DNase I digestion of DNA were shown in Fig. 2A. Methylated or DNase I-treated DNA from HKBA were no longer able to induce IL-12p40 from mouse splenocytes (Fig. 2B). These results confirm that the stimulatory ability of DNA from HKBA resides in unmethylated CpG motifs contained in the DNA.



View larger version (34K):
[in this window]
[in a new window]
  		FIGURE 2. Methylation and DNase I treatment abrogate the ability of DNA from HKBA to induce IL-12p40 in splenocytes. A, DNA-BA was methylated using SssI methylase and treated with DNase I and DNA was visualized after electrophoresis on ethidium bromide-stained 1% agarose gels. Lane M, {lambda} and {varphi}{chi}174 DNA markers from Invitrogen Life Technologies; lane 1, methylated DNA-BA; lane 2, mock-methylated DNA-BA (treated with buffer and SAM only); lane 3, methylated DNA-BA resistant to HpaII cleavage; lane 4, mock-methylated DNA-BA susceptible to HpaII cleavage (~5 µg/lane 1-4); lane 5, DNase I-treated DNA-BA; lane 6, mock-DNase I DNA-BA treated, buffer only (~3 µg, lanes 5 and 6). B, DNA (~25 µg/ml) treated in various ways, medium, and DNase I buffer were added to splenocytes of WT mice. Supernatants were collected after overnight incubation and assayed for IL-12p40 by ELISA. The mean values and SDs are shown. *, Values of p < 0.05. The data shown are representative of two similar experiments.

 
sODN inhibit HKBA induction of IL-12p40 secretion

sODN have been shown to block the signaling cascade initiated by CpG DNA (38, 44, 45, 46, 47, 48). There are two classes of sODNs, those that suppress broadly (45, 48) and other ODNs that are selective for interaction of CpG with TLR9 (38, 44, 47). To determine whether HKBA mediated IL-12p40 secretion is a consequence of the interaction between bacterial DNA and TLR9, H154 sODN that is selective for CpG suppression was used. It inhibited induction of IL-12p40 secretion by HKBA in a manner similar to that seen with CpG ODN. These data support the notion that DNA from HKBA is indeed responsible for the secretion of IL-12p40, probably via engagement of TLR9 (Fig. 3).



View larger version (28K):
[in this window]
[in a new window]
  		FIGURE 3. sODN inhibit IL-12p40 induction in DC by HKBA and CpG ODN in a dose-dependent manner. sODN were added to cultures of DC enriched from spleens of WT mice, then stimulated with HKBA (108 organisms per milliliter) or CpG ODN (2 µM). Supernatants were collected after overnight incubation and assayed for IL-12p40 by ELISA. The mean values and SDs are shown. *, Values of p < 0.05. The data shown are representative of three similar experiments.

 
Recognition of HKBA in DC by TLR9 requires endosomal acidification

HKBA exists as particles of various sizes. To access TLR9, which is situated intracellularly and translocates from the endoplasmic reticulum to endosomes after activation (49, 50), HKBA would have to be phagocytosed and phagolysosomes would need to fuse with endosomes. To examine whether HKBA stimulation of IL-12 p40 required endosomal acidification, chloroquine was added and shown to inhibit CpG and HKBA-induced IL-12p40 in a dose-dependent manner in WT mice (Fig. 4). This suggests that HKBA and CpG have similar requirements for stimulation of TLR9 and IL-12p40 secretion and localize to endosomes where they engage TLR9.



View larger version (29K):
[in this window]
[in a new window]
  		FIGURE 4. Chloroquine inhibits IL-12p40 induction in DC by HKBA and CpG ODN in a dose-dependent manner. Chloroquine was added to cultures of DC enriched from spleens of WT mice that were stimulated with HKBA (108 organisms per milliliter) and CpG ODN (2 µM), and IL-12p40 assayed from supernatants was collected 24 h later. The mean values and SDs are shown. *, Values of p < 0.05. The data shown are representative of three similar experiments.

 
HKBA stimulation of IL-12p40 in vivo in mice is MyD88 dependent but only partially TLR9 dependent

As shown previously, IL-12p40 secretion after HKBA stimulation in vivo is MyD88 dependent, but TLR2/4 independent. When injected in vivo, HKBA induced detectable serum IL-12p40 in WT mice, but not in mice with defective MyD88 expression, as was seen in vitro (Fig. 5). However, when TLR9–/– mice were used, IL-12p40 levels were only partially reduced throughout the time points examined, unlike the complete TLR9 dependency observed in vitro with DC (Fig. 1). In contrast, IL-12p40 secretion induced by CpG was totally abolished in TLR9–/– mice (Fig. 5).



View larger version (21K):
[in this window]
[in a new window]
  		FIGURE 5. In vivo induction of IL-12p40 by HKBA is totally MyD88 dependent, but only partially TLR9 dependent. HKBA (108 organisms) or CpG ODN (100 µg of CpG1555) were injected i.p. into WT, MyD88–/–, and TLR9–/– mice, and sera were collected at different time points and assayed for IL-12p40 production by ELISA. The values shown for PBS-injected mice are the means for the three different time points. Numbers of mice (n = 6–12) were used in the WT, TLR9–/–, and MyD88–/– mice at different time points. The mean values and SEs are shown. *, Values of p < 0.05 for that group, compared with the WT group receiving the same stimulus at the same time point.

 
To further characterize the in vivo response, WT mice were injected with HKBA in the presence and absence of sODNs. Unlike what was observed in vitro, sODNs only partially inhibited HKBA-induced IL-12p40 in WT mice, but totally inhibited CpG-induced IL-12p40. The finding that sODN had no effect on IL-12p40 secretion after HKBA stimulation in vivo in TLR9–/– mice was expected and attests to the specificity of H154 sODN to inhibit CpG interaction with TLR9 but not other pathways for IL-12p40 induction. Nonstimulatory ODNs were used as a control (Fig. 6). As an additional control, LPS E. coli stimulation of IL-12p40 in vivo was shown to be unaffected by sODN (data not shown).



View larger version (29K):
[in this window]
[in a new window]
  		FIGURE 6. In vivo induction of IL-12p40 by HKBA, unlike CpG ODN, is only partially reduced by sODN. HKBA (108 organisms) or CpG ODN (100 µg of CpG1555) was injected into WT mice in the presence or absence of sODN or cODN. HKBA was also injected into WT and TLR9–/– mice in the presence or absence of sODN (150 µg of ODN H154) or cODN (150 µg of ODN 1471). Sera were harvested 3 h later and assayed for IL-12p40 production by ELISA. The mean values and SEs are shown. *, Values of p < 0.05. The data shown are representative of two similar experiments.

 
These findings suggest that HKBA-induced IL-12p40 production in vivo is likely to be dependent on at least two distinct TLR pathways, only one of which is TLR9 dependent.

HKBA stimulation of macrophages, but not B cells, in vitro elicits IL-12p40 secretion, which is MyD88 dependent, but only partially TLR9 dependent

The discrepancy between DC and in vivo responses to HKBA could be due to the fact that, in addition to DC, other cell types, e.g., macrophages and B cells, that express TLR9, could respond to HKBA in vivo in a TLR9-independent manner. Stimulation of peritoneal macrophages from WT mice resulted in IL-12p40 production. This effect was abolished in MyD88–/– mice but only partially decreased in TLR9–/– mice (Fig. 7). This indicates that macrophages, unlike DC, are only partially dependent on TLR9 for induction of IL-12p40 after stimulation with HKBA. In contrast, induction of IL-12p40 by LPS E. coli, which acts via TLR4, was not reduced in TLR9–/– mice. Previously we showed that induction of IL-12 p40 by HKBA in macrophages is TLR2/4-independent (Ref.19 and our unpublished data). These observations may provide an explanation for the difference between stimulation by HKBA of DC in vitro (TLR9 dependent) and mice in vivo (partially TLR9 dependent).



View larger version (17K):
[in this window]
[in a new window]
  		FIGURE 7. IL-12p40 induction by HKBA in peritoneal macrophages, unlike DNA from HKBA and CpG ODN, is only partially TLR9 dependent. Peritoneal macrophages from WT, MyD88–/–, and TLR9–/– mice were harvested and placed in culture with HKBA (108 organisms per milliliter) or DNA from HKBA (15 µg/ml), CpG ODN (1 µM), or LPS derived from E. coli (20 µg/ml). Supernatants were collected 24 h later and assayed for IL-12p40. ND, Not detected. The data shown are representative of four similar experiments.

 
To investigate the role of B cells in the partial in vivo IL-12p40 response to HKBA, mouse B cells were purified from splenocytes by using CD19 MACS beads (Miltenyi Biotec). WT and TLR9–/– mouse B cells were stimulated with HKBA and CpG, and low levels of IL-12p40 protein were induced in WT cells, but not in TLR9–/– cells. However, the HKBA and CpG induced high levels of IL-6 in WT B cells confirming that the B cells were functional (data not shown). These results indicate that B cells contribute minimally to the partial IL-12p40 response of TLR9–/– mice to HKBA in vivo.

HKBA induction of IFN-{gamma} and IFN-{alpha} in vivo is TLR9 dependent

WT and TLR9–/– mice were inoculated i.p. with HKBA, and IFN-{gamma} levels were measured in serum samples at various time points (Fig. 8A). In WT mice, maximal IFN-{gamma} responses were observed at 6–8 h but these were markedly reduced in TLR9–/– mice (Fig. 8A) and were absent in MyD88–/– (data not shown). These results indicate that the IL-12p40 detected in vivo at 2–8 h (Fig. 5) represents functional IL-12 that precedes and likely induces the subsequent IFN-{gamma} secretion. Previously, we have shown that HKBA stimulates DC to migrate to T cell areas and secrete IL-12p40. Increases in IL-12 and IFN-{gamma} provide an environment that would favor Th1-like responses.



View larger version (19K):
[in this window]
[in a new window]
  		FIGURE 8. Induction of IFN-{gamma} and IFN-{alpha} by HKBA is TLR9 dependent. C57BL/6 and TLR9–/– mice were injected with HKBA (108 organisms) and sera were collected at different time points and assayed for IFN-{gamma} (A) and IFN-{alpha} (B). Numbers of mice (n = 5) were used in the WT and TLR9–/– mice at different time points. *, Values of p < 0.05 for that group, compared with the WT group receiving the same stimulus at the same time point. ND, Not detected. The data shown are representative of three similar experiments.

 
Type 1 IFNs have been associated with viral infections, but IFN-{alpha} can also be induced by certain bacteria (29) and by D-type ODNs, but not K-type ODNs (24, 51, 52). In this report, we show that HKBA can also induce IFN-{alpha} as measured in the serum (Fig. 8B). Serum IFN-{alpha} was detected within 3 h after HKBA injection, and the level was absent from MyD88–/– mice (data not shown) and markedly reduced in the serum from TLR9–/– mice (Fig. 8B). To our knowledge, this is the first demonstration that a bacterium induces IFN-{alpha} by a TLR9-dependent mechanism.


   Discussion
Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
Disclosures
 References
 
Previously we showed that B. abortus activated cells of the innate immune system and more specifically via TLR triggering in DC and macrophages. In vitro and in vivo data from MyD88–/– mice indicate that HKBA induction of both TNF and IL-12p40 secretion require an intact MyD88 pathway. MyD88 is an adaptor molecule that participates in all known TLR pathways (except TLR3) and also functions in IL-1 and IL-18 receptor signaling (20, 31). Interestingly, based on experiments with targeted deletion of TLR2 or mutation of TLR4, induction of TNF and IL-12p40 involve different TLRs, such that TLR2 is required for TNF, but not IL-12p40 production. TLR4 is not required for either TNF or IL-12p40 induction by HKBA (19).

In the present study, we show that HKBA interacts with TLR9 to induce IL-12p40 secretion in murine DC. This effect is likely to be mediated by bacterial DNA from HKBA, because it was also seen with DNA extracted from HKBA and was inhibited by sODN, selective for CpG suppression. Scanning both chromosomes of the Brucella genome revealed that this species contains higher levels of CpG dinucleotide (0.0916) than average bacteria (0.0625) and even higher levels than E. coli (0.0747) (41, 42, 43). Moreover, when DNA from HKBA was treated with DNase I or methylation, it lost its ability to stimulate IL-12p40.

TLR9 was recently shown to translocate from the endoplasmic reticulum to the endosome after cell activation (53, 54). Chloroquine has been shown to interfere with endosomal acidification which is required for CpG-mediated signaling of TLR9 (52, 55, 56). Thus, the fact that chloroquine blocked the effect of HKBA on IL-12p40 secretion by DC, supports the notion that DNA derived from HKBA and TLR9 probably interacts in endosomes. Wortmannin, another inhibitor of CpG uptake into TLR9-containing endosomes (57), was also effective in blocking HKBA from eliciting IL-12p40 secretion (data not shown). Even though triggering of TLR9 by synthetic unmethylated CpG-bearing ODNs is well known, this is the first demonstration that a bacterium can enter a cell and stimulate TLR9 via its DNA.

The dose of HKBA that elicited optimal IL-12p40 secretion in DC was 108 organisms. This dose contains ~500 ng/ml DNA, far less than the amount of purified DNA required, i.e., 25 µg/ml to elicit IL-12p40 secretion (34). This indicates that the DNA packaged in HKBA is more potent than purified DNA, possibly because the DNA from HKBA is released within the cells and is less vulnerable to degradation during processing. Alternatively, HKBA provides other signals that enhance stimulation via TLR9. Previously we showed that, although DNA purified from HKBA lost activity after digestion with DNase, DNase or proteinase K digestions did not alter HKBA ability to induce cytokines in vitro (34), suggesting that the DNA in HKBA is protected from enzyme degradation. Taken together, these results support the hypothesis stated by Takeda and Akira (20) that bacteria are engulfed by DC and, after processing in phagosomes/lysosomes or endosomes/lysosomes, CpG DNA is exposed and interacts with TLR9.

In vivo HKBA elicited secretion of IL-12p40 in a MyD88-dependent manner. However, unlike DC in vitro, this effect was only partially reduced in TLR9–/– mice. This discrepancy could be due to secretion of IL-12p40 in vivo by other cells, e.g., macrophages or B cells that can use other TLR pathways to secrete IL-12p40. B cells made little IL-12p40 in response to HKBA in vitro, and hence probably do not contribute to the partial IL-12p40 response observed in TLR9–/– mice in vivo. However, when macrophages were studied in vitro, IL-12p40 secretion after activation by HKBA was found to be MyD88 dependent but only partially dependent on TLR9. These findings suggest that other TLRs are involved in triggering macrophages to secrete IL-12p40 after HKBA stimulation, although we have previously excluded TLR2/4 (19). The role of systemically increased IL-12 during an infection may be important in activation of NK cells and in bystander cell effects. However, it is likely that the local release of IL-12 by DC in T cell areas is critical for specific T cell and adaptive responses to the infectious agent. The IL-12 induced was probably functionally effective because IFN-{gamma} was also observed in the serum of WT mice injected with HKBA. As expected, the IFN-{gamma} induction was MyD88 and TLR9 dependent.

Because TLR9 ligation can result in IFN-{alpha} induction as a result of engagement by viral DNA or D-type CpG ODNs (24, 26, 58, 59, 60), it was of interest to determine the effect of HKBA on IFN-{alpha} secretion. IFN-{alpha} was observed within 3 h in the serum of WT, but not MyD88–/– or TLR9–/–, mice injected with HKBA. To our knowledge, this is the first report indicating that HKBA induces IFN-{alpha} in a TLR9-dependent manner. This effect enhances the potential of HKBA as a Th1-like vaccine delivery system for viruses and bacteria.

The picture emerging from this and our previous studies is that HKBA acts on the immune system by stimulating DC via TLR2 to secrete TNF and undergo maturation followed by migration to T cell areas. As suggested by us (19) and confirmed by others, the TLR2 ligand on HKBA is lipoprotein (61). DC in T cell areas are stimulated by DNA from HKBA via TLR9 to secrete IL-12p40, which in turn activates nearby T cells to differentiate as Th1 cells and secrete IFN-{gamma}. By chemically linking, or by expressing peptides or proteins, using recombinant technology, to HKBA, they can be internalized by DC and presented to appropriate T cells, so that desired specific Th1 cell responses can be achieved (9, 62).

Interestingly, stimulation of TLR2 has been shown by others to promote a Th2-like response (63, 64), whereas activation of TLR9 favors a Th1-like outcome. Because HKBA stimulates both TLR2 and TLR9, a mixed Th1/Th2 response may be expected. In fact, as we have shown previously, a Th1-like response predominates (62). This situation is probably operative with other microorganisms in that they may stimulate two or more TLRs and the outcome may be Th1- or Th2-like depending on the predominant pathway and inherent host differences (65).


   Acknowledgments
 
We are grateful to Drs. Hana Golding and Mayda Gursel for review of the manuscript, and Dr. Shinichiro Tsunoda for technical advice.


   Disclosures
Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 Disclosures
References
 
The authors have no financial conflict of interest.


   Footnotes
 
The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked advertisement in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

1 Address correspondence and reprint requests to Dr. Basil Golding, Building 29, Room 328, Food and Drug Administration, 1401 Rockville Pike (HFM-345), Rockville, MD 20852. E-mail address: Golding{at}cber.fda.gov Back

2 Abbreviations used in this paper: HKBA, heat-killed B. abortus; ODN, oligodeoxynucleotide; DC, dendritic cell; SAM, S-adenosylmethionine; sODN, suppressive ODN; STAg, soluble T. gondii tachyzoite Ag; WT, wild type; cODN, control ODN; DNA-BA, B. abortus DNA. Back

Received for publication March 17, 2005. Accepted for publication July 5, 2005.


   References
Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 Disclosures
 References
 

  1. Golding, B., D. E. Scott, O. Scharf, L. Y. Huang, M. Zaitseva, C. Lapham, N. Eller, H. Golding. 2001. Immunity and protection against Brucella abortus. Microbes Infect. 3:43.-48. [Medline]
  2. Corbel, M. J.. 1997. Brucellosis: an overview. Emerg. Infect. Dis. 3:213.-221. [Medline]
  3. Baldwin, C. L., M. Parent. 2002. Fundamentals of host immune response against Brucella abortus: what the mouse model has revealed about control of infection. Vet. Microbiol. 90:367.-382. [Medline]
  4. Schurig, G. G., N. Sriranganathan, M. J. Corbel. 2002. Brucellosis vaccines: past, present and future. Vet. Microbiol. 90:479.-496. [Medline]
  5. Ko, J., G. A. Splitter. 2003. Molecular host-pathogen interaction in brucellosis: current understanding and future approaches to vaccine development for mice and humans. Clin. Microbiol. Rev. 16:65.-78. [Abstract/Free Full Text]
  6. Ficht, T. A.. 2003. Intracellular survival of Brucella: defining the link with persistence. Vet. Microbiol. 92:213.-223. [Medline]
  7. Gorvel, J. P., E. Moreno. 2002. Brucella intracellular life: from invasion to intracellular replication. Vet. Microbiol. 90:281.-297. [Medline]
  8. Zhan, Y., C. Cheers. 1998. Control of IL-12 and IFN-{gamma} production in response to live or dead bacteria by TNF and other factors. J. Immunol. 161:1447.-1453. [Abstract/Free Full Text]
  9. Huang, L. Y., C. Reis e Sousa, Y. Itoh, J. Inman, D. E. Scott. 2001. IL-12 induction by a TH1-inducing adjuvant in vivo: dendritic cell subsets and regulation by IL-10. J. Immunol. 167:1423.-1430. [Abstract/Free Full Text]
  10. Mosmann, T. R., R. L. Coffman. 1989. TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties. Annu. Rev. Immunol. 7:145.-173. [Medline]
  11. Mosmann, T. R., S. Sad. 1996. The expanding universe of T-cell subsets: Th1, Th2 and more. Immunol. Today 17:138.-146. [Medline]
  12. Zaitseva, M. B., H. Golding, M. Betts, A. Yamauchi, E. T. Bloom, L. E. Butler, L. Stevan, B. Golding. 1995. Human peripheral blood CD4+ and CD8+ T cells express Th1-like cytokine mRNA and proteins following in vitro stimulation with heat-inactivated Brucella abortus. Infect. Immun. 63:2720.-2728. [Abstract]
  13. Zaitseva, M., L. R. King, J. Manischewitz, M. Dougan, L. Stevan, H. Golding, B. Golding. 2001. Human peripheral blood T cells, monocytes, and macrophages secrete macrophage inflammatory proteins 1{alpha} and 1{beta} following stimulation with heat-inactivated Brucella abortus. Infect. Immun. 69:3817.-3826. [Abstract/Free Full Text]
  14. Mond, J. J., I. Scher, D. E. Mosier, M. Baese, W. E. Paul. 1978. T-independent responses in B cell-defective CBA/N mice to Brucella abortus and to trinitrophenyl (TNP) conjugates of Brucella abortus. Eur. J. Immunol. 8:459.-463. [Medline]
  15. Lapham, C., B. Golding, J. Inman, R. Blackburn, J. Manischewitz, P. Highet, H. Golding. 1996. Brucella abortus conjugated with a peptide derived from the V3 loop of human immunodeficiency virus (HIV) type 1 induces HIV-specific cytotoxic T-cell responses in normal and in CD4+ cell-depleted BALB/c mice. J. Virol. 70:3084.-3092. [Abstract]
  16. Lane, H. C., A. S. Fauci. 1985. Immunologic abnormalities in the acquired immunodeficiency syndrome. Annu. Rev. Immunol. 3:477.-500. [Medline]
  17. Golding, B., J. Inman, P. Highet, R. Blackburn, J. Manischewitz, N. Blyveis, R. D. Angus, H. Golding. 1995. Brucella abortus conjugated with a gp120 or V3 loop peptide derived from human immunodeficiency virus (HIV) type 1 induces neutralizing anti-HIV antibodies, and the V3-B. abortus conjugate is effective even after CD4+ T-cell depletion. J. Virol. 69:3299.-3307. [Abstract]
  18. Scott, D. E., H. Golding, L. Y. Huang, J. Inman, B. Golding. 1998. HIV peptide conjugated to heat-killed bacteria promotes antiviral responses in immunodeficient mice. AIDS Res. Hum. Retroviruses 14:1263.-1269. [Medline]
  19. Huang, L. Y., J. Aliberti, C. A. Leifer, D. M. Segal, A. Sher, D. T. Golenbock, B. Golding. 2003. Heat-killed Brucella abortus induces TNF and IL-12p40 by distinct MyD88-dependent pathways: TNF, unlike IL-12p40 secretion, is Toll-like receptor 2 dependent. J. Immunol. 171:1441.-1446. [Abstract/Free Full Text]
  20. Takeda, K., S. Akira. 2005. Toll-like receptors in innate immunity. Int. Immunol. 17:1.-14. [Abstract/Free Full Text]
  21. Barton, G. M., R. Medzhitov. 2003. Toll-like receptor signaling pathways. Science 300:1524.-1525. [Abstract/Free Full Text]
  22. Vogel, S. N., K. A. Fitzgerald, M. J. Fenton. 2003. TLRs: differential adapter utilization by Toll-like receptors mediates TLR-specific patterns of gene expression. Mol. Interv. 3:466.-477. [Abstract/Free Full Text]
  23. O’Neill, L. A., K. A. Fitzgerald, A. G. Bowie. 2003. The Toll-IL-1 receptor adaptor family grows to five members. Trends Immunol. 24:286.-290. [Medline]
  24. Hemmi, H., T. Kaisho, K. Takeda, S. Akira. 2003. The roles of Toll-like receptor 9, MyD88, and DNA-dependent protein kinase catalytic subunit in the effects of two distinct CpG DNAs on dendritic cell subsets. J. Immunol. 170:3059.-3064. [Abstract/Free Full Text]
  25. Kawai, T., S. Sato, K. J. Ishii, C. Coban, H. Hemmi, M. Yamamoto, K. Terai, M. Matsuda, J. Inoue, S. Uematsu, et al 2004. Interferon-{alpha} induction through Toll-like receptors involves a direct interaction of IRF7 with MyD88 and TRAF6. Nat. Immunol. 5:1061.-1068. [Medline]
  26. Krug, A., S. Rothenfusser, V. Hornung, B. Jahrsdorfer, S. Blackwell, Z. K. Ballas, S. Endres, A. M. Krieg, G. Hartmann. 2001. Identification of CpG oligonucleotide sequences with high induction of IFN-{alpha}/{beta} in plasmacytoid dendritic cells. Eur. J. Immunol. 31:2154.-2163. [Medline]
  27. Le Bon, A., D. F. Tough. 2002. Links between innate and adaptive immunity via type I interferon. Curr. Opin. Immunol. 14:432.-436. [Medline]
  28. Decker, T., S. Stockinger, M. Karaghiosoff, M. Muller, P. Kovarik. 2002. IFNs and STATs in innate immunity to microorganisms. J. Clin. Invest. 109:1271.-1277. [Medline]
  29. Bogdan, C., J. Mattner, U. Schleicher. 2004. The role of type I interferons in non-viral infections. Immunol. Rev. 202:33.-48. [Medline]
  30. Santini, S. M., T. Di Pucchio, C. Lapenta, S. Parlato, M. Logozzi, F. Belardelli. 2002. The natural alliance between type I interferon and dendritic cells and its role in linking innate and adaptive immunity. J. Interferon Cytokine Res. 22:1071.-1080. [Medline]
  31. Adachi, O., T. Kawai, K. Takeda, M. Matsumoto, H. Tsutsui, M. Sakagami, K. Nakanishi, S. Akira. 1998. Targeted disruption of the MyD88 gene results in loss of IL-1- and IL-18-mediated function. Immunity 9:143.-150. [Medline]
  32. Hemmi, H., O. Takeuchi, T. Kawai, T. Kaisho, S. Sato, H. Sanjo, M. Matsumoto, K. Hoshino, H. Wagner, K. Takeda, S. Akira. 2000. A Toll-like receptor recognizes bacterial DNA. Nature 408:740.-745. [Medline]
  33. Grunvald, E., M. Chiaramonte, S. Hieny, M. Wysocka, G. Trinchieri, S. N. Vogel, R. T. Gazzinelli, A. Sher. 1996. Biochemical characterization and protein kinase C dependency of monokine-inducing activities of Toxoplasma gondii. Infect. Immun. 64:2010.-2018. [Abstract]
  34. Huang, L.-Y., A. M. Krieg, N. Eller, D. E. Scott. 1999. Induction and regulation of Th1-inducing cytokines by bacterial DNA, lipopolysaccharide, and heat-inactivated bacteria. Infect. Immun. 67:6257.-6263. [Abstract/Free Full Text]
  35. Sun, S., Z. Cai, P. Langlade-Demoyen, H. Kosaka, A. Brunmark, M. R. Jackson, P. A. Peterson, J. Sprent. 1996. Dual function of Drosophila cells as APCs for naive CD8+ T cells: implications for tumor immunotherapy. Immunity 4:555.-564. [Medline]
  36. Brown, W. C., D. M. Estes, S. E. Chantler, K. A. Kegerreis, C. E. Suarez. 1998. DNA and a CpG oligonucleotide derived from Babesia bovis are mitogenic for bovine B cells. Infect. Immun. 66:5423.-5432. [Abstract/Free Full Text]
  37. Halling, S. M., B. D. Peterson-Burch, B. J. Bricker, R. L. Zuerner, Z. Qing, L. L. Li, V. Kapur, D. P. Alt, S. C. Olsen. 2005. Completion of the genome sequence of Brucella abortus and comparison to the highly similar genomes of Brucella melitensis and Brucella suis. J. Bacteriol. 187:2715.-2726. [Abstract/Free Full Text]
  38. Yamada, H., I. Gursel, F. Takeshita, J. Conover, K. J. Ishii, M. Gursel, S. Takeshita, D. M. Klinman. 2002. Effect of suppressive DNA on CpG-induced immune activation. J. Immunol. 169:5590.-5594. [Abstract/Free Full Text]
  39. Aliberti, J., C. Reis e Sousa, M. Schito, S. Hieny, T. Wells, G. B. Huffnagle, A. Sher. 2000. CCR5 provides a signal for microbial induced production of IL-12 by CD8{alpha}+ dendritic cells. Nat. Immunol. 1:83.-87. [Medline]
  40. Scanga, C. A., J. Aliberti, D. Jankovic, F. Tilloy, S. Bennouna, E. Y. Denkers, R. Medzhitov, A. Sher. 2002. Cutting edge: MyD88 is required for resistance to Toxoplasma gondii infection and regulates parasite-induced IL-12 production by dendritic cells. J. Immunol. 168:5997.-6001. [Abstract/Free Full Text]
  41. Bird, A. P.. 1987. CpG islands as gene markers in the vertebrate nucleus. Trends Genet. 3:342.-347.
  42. Krieg, A. M., A. K. Yi, S. Matson, T. J. Waldschmidt, G. A. Bishop, R. Teasdale, G. A. Koretzky, D. M. Klinman. 1995. CpG motifs in bacterial DNA trigger direct B-cell activation. Nature 374:546.-549. [Medline]
  43. Stacey, K. J., G. R. Young, F. Clark, D. P. Sester, T. L. Roberts, S. Naik, M. J. Sweet, D. A. Hume. 2003. The molecular basis for the lack of immunostimulatory activity of vertebrate DNA. J. Immunol. 170:3614.-3620. [Abstract/Free Full Text]
  44. Krieg, A. M., T. Wu, R. Weeratna, S. M. Efler, L. Love-Homan, L. Yang, A. K. Yi, D. Short, H. L. Davis. 1998. Sequence motifs in adenoviral DNA block immune activation by stimulatory CpG motifs. Proc. Natl. Acad. Sci. USA 95:12631.-12636. [Abstract/Free Full Text]
  45. Zhu, F. G., C. F. Reich, D. S. Pisetsky. 2002. Inhibition of murine dendritic cell activation by synthetic phosphorothioate oligodeoxynucleotides. J. Leukocyte Biol. 72:1154.-1163. [Abstract/Free Full Text]
  46. Ishii, K. J., I. Gursel, M. Gursel, D. M. Klinman. 2004. Immunotherapeutic utility of stimulatory and suppressive oligodeoxynucleotides. Curr. Opin. Mol. Ther. 6:166.-174. [Medline]
  47. Stunz, L. L., P. Lenert, D. Peckham, A. K. Yi, S. Haxhinasto, M. Chang, A. M. Krieg, R. F. Ashman. 2002. Inhibitory oligonucleotides specifically block effects of stimulatory CpG oligonucleotides in B cells. Eur. J. Immunol. 32:1212.-1222. [Medline]
  48. Shirota, H., I. Gursel, M. Gursel, D. M. Klinman. 2005. Suppressive oligodeoxynucleotides protect mice from lethal endotoxic shock. J. Immunol. 174:4579.-4583. [Abstract/Free Full Text]
  49. Wagner, H.. 2004. The immunobiology of the TLR9 subfamily. Trends Immunol. 25:381.-386. [Medline]
  50. Latz, E., A. Visintin, T. Espevik, D. T. Golenbock. 2004. Mechanisms of TLR9 activation. J. Endotoxin Res. 10:406.-412.
  51. Verthelyi, D., K. J. Ishii, M. Gursel, F. Takeshita, D. M. Klinman. 2001. Human peripheral blood cells differentially recognize and respond to two distinct CPG motifs. J. Immunol. 166:2372.-2377. [Abstract/Free Full Text]
  52. Krieg, A. M.. 2002. CpG motifs in bacterial DNA and their immune effects. Annu. Rev. Immunol. 20:709.-760. [Medline]
  53. Latz, E., A. Schoenemeyer, A. Visintin, K. A. Fitzgerald, B. G. Monks, C. F. Knetter, E. Lien, N. J. Nilsen, T. Espevik, D. T. Golenbock. 2004. TLR9 signals after translocating from the ER to CpG DNA in the lysosome. Nat. Immunol. 5:190.-198. [Medline]
  54. Leifer, C. A., M. N. Kennedy, A. Mazzoni, C. Lee, M. J. Kruhlak, D. M. Segal. 2004. TLR9 is localized in the endoplasmic reticulum prior to stimulation. J. Immunol. 173:1179.-1183. [Abstract/Free Full Text]
  55. Ahmad-Nejad, P., H. Hacker, M. Rutz, S. Bauer, R. M. Vabulas, H. Wagner. 2002. Bacterial CpG-DNA and lipopolysaccharides activate Toll-like receptors at distinct cellular compartments. Eur. J. Immunol. 32:1958.-1968. [Medline]
  56. Takeshita, F., C. A. Leifer, I. Gursel, K. J. Ishii, S. Takeshita, M. Gursel, D. M. Klinman. 2001. Cutting edge: role of Toll-like receptor 9 in CpG DNA-induced activation of human cells. J. Immunol. 167:3555.-3558. [Abstract/Free Full Text]
  57. Ishii, K. J., F. Takeshita, I. Gursel, M. Gursel, J. Conover, A. Nussenzweig, D. M. Klinman. 2002. Potential role of phosphatidylinositol 3 kinase, rather than DNA-dependent protein kinase, in CpG DNA-induced immune activation. J. Exp. Med. 196:269.-274. [Abstract/Free Full Text]
  58. Lund, J., A. Sato, S. Akira, R. Medzhitov, A. Iwasaki. 2003. Toll-like receptor 9-mediated recognition of Herpes simplex virus-2 by plasmacytoid dendritic cells. J. Exp. Med. 198:513.-520. [Abstract/Free Full Text]
  59. Verthelyi, D., R. A. Zeuner. 2003. Differential signaling by CpG DNA in DCs and B cells: not just TLR9. Trends Immunol. 24:519.-522. [Medline]
  60. Kerkmann, M., S. Rothenfusser, V. Hornung, A. Towarowski, M. Wagner, A. Sarris, T. Giese, S. Endres, G. Hartmann. 2003. Activation with CpG-A and CpG-B oligonucleotides reveals two distinct regulatory pathways of type I IFN synthesis in human plasmacytoid dendritic cells. J. Immunol. 170:4465.-4474. [Abstract/Free Full Text]
  61. Giambartolomei, G. H., A. Zwerdling, J. Cassataro, L. Bruno, C. A. Fossati, M. T. Philipp. 2004. Lipoproteins, not lipopolysaccharide, are the key mediators of the proinflammatory response elicited by heat-killed Brucella abortus. J. Immunol. 173:4635.-4642. [Abstract/Free Full Text]
  62. Scott, D. E., I. Agranovich, J. Inman, M. Gober, B. Golding. 1997. Inhibition of primary and recall allergen-specific T helper cell type 2-mediated responses by a T helper cell type 1 stimulus. J. Immunol. 159:107.-116. [Abstract]
  63. Redecke, V., H. Hacker, S. K. Datta, A. Fermin, P. M. Pitha, D. H. Broide, E. Raz. 2004. Cutting edge: activation of Toll-like receptor 2 induces a Th2 immune response and promotes experimental asthma. J. Immunol. 172:2739.-2743. [Abstract/Free Full Text]
  64. Sun, J., M. Walsh, A. V. Villarino, L. Cervi, C. A. Hunter, Y. Choi, E. J. Pearce. 2005. TLR ligands can activate dendritic cells to provide a MyD88-dependent negative signal for Th2 cell development. J. Immunol. 174:742.-751. [Abstract/Free Full Text]
  65. Khan, A. Q., Q. Chen, Z. Q. Wu, J. C. Paton, C. M. Snapper. 2005. Both innate immunity and type 1 humoral immunity to Streptococcus pneumoniae are mediated by MyD88 but differ in their relative levels of dependence on Toll-like receptor 2. Infect. Immun. 73:298.-307. [Abstract/Free Full Text]



This article has been cited by other articles:


Home page
 Infect. Immun.Home page
U. Bhan, G. Trujillo, K. Lyn-Kew, M. W. Newstead, X. Zeng, C. M. Hogaboam, A. M. Krieg, and T. J. Standiford
Toll-Like Receptor 9 Regulates the Lung Macrophage Phenotype and Host Immunity in Murine Pneumonia Caused by Legionella pneumophila
Infect. Immun., July 1, 2008; 76(7): 2895 - 2904.
[Abstract] [Full Text] [PDF]

Home page
 J. Leukoc. Biol.Home page
S. C. Nance, A.-K. Yi, F. C. Re, and E. A. Fitzpatrick
MyD88 is necessary for neutrophil recruitment in hypersensitivity pneumonitis
J. Leukoc. Biol., May 1, 2008; 83(5): 1207 - 1217.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
G. C. Macedo, D. M. Magnani, N. B. Carvalho, O. Bruna-Romero, R. T. Gazzinelli, and S. C. Oliveira
Central Role of MyD88-Dependent Dendritic Cell Maturation and Proinflammatory Cytokine Production to Control Brucella abortus Infection
J. Immunol., January 15, 2008; 180(2): 1080 - 1087.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
U. Bhan, N. W. Lukacs, J. J. Osterholzer, M. W. Newstead, X. Zeng, T. A. Moore, T. R. McMillan, A. M. Krieg, S. Akira, and T. J. Standiford
TLR9 Is Required for Protective Innate Immunity in Gram-Negative Bacterial Pneumonia: Role of Dendritic Cells
J. Immunol., September 15, 2007; 179(6): 3937 - 3946.
[Abstract] [Full Text] [PDF]

Home page
 Infect. Immun.Home page
J. B. Ewaschuk, J. L. Backer, T. A. Churchill, F. Obermeier, D. O. Krause, and K. L. Madsen
Surface Expression of Toll-Like Receptor 9 Is Upregulated on Intestinal Epithelial Cells in Response to Pathogenic Bacterial DNA
Infect. Immun., May 1, 2007; 75(5): 2572 - 2579.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
R. Copin, P. De Baetselier, Y. Carlier, J.-J. Letesson, and E. Muraille
MyD88-Dependent Activation of B220-CD11b+LY-6C+ Dendritic Cells during Brucella melitensis Infection
J. Immunol., April 15, 2007; 178(8): 5182 - 5191.
[Abstract] [Full Text] [PDF]

Home page
 Infect. Immun.Home page
C. A. Newton, I. Perkins, R. H. Widen, H. Friedman, and T. W. Klein
Role of Toll-Like Receptor 9 in Legionella pneumophila-Induced Interleukin-12 p40 Production in Bone Marrow-Derived Dendritic Cells and Macrophages from Permissive and Nonpermissive Mice
Infect. Immun., January 1, 2007; 75(1): 146 - 151.
[Abstract] [Full Text] [PDF]

Home page
 Infect. Immun.Home page
T. H. Harris, N. M. Cooney, J. M. Mansfield, and D. M. Paulnock
Signal transduction, gene transcription, and cytokine production triggered in macrophages by exposure to trypanosome DNA.
Infect. Immun., August 1, 2006; 74(8): 4530 - 4537.
[Abstract] [Full Text] [PDF]

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow